1201930-28-0

Basic information

• Product Name: [3-(5-bromopyrimidin-2-yl)phenyl]acetic acid
• Synonyms: [3-(5-bromopyrimidin-2-yl)phenyl]acetic acid
• CAS NO: 1201930-28-0
• Molecular Weight: 293.12
• Mol File: 1201930-28-0.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: [3-(5-bromopyrimidin-2-yl)phenyl]acetic acid(CAS DataBase Reference)
• NIST Chemistry Reference: [3-(5-bromopyrimidin-2-yl)phenyl]acetic acid(1201930-28-0)
• EPA Substance Registry System: [3-(5-bromopyrimidin-2-yl)phenyl]acetic acid(1201930-28-0)

Safety Data

• Hazardous Substances Data: 1201930-28-0(Hazardous Substances Data)

Upstream product

• 1878-67-7 3-Bromophenylacetic acid 
• 150529-73-0 methyl 2-(3-bromophenyl)acetatee 
• 183438-24-6 5-bromo-2-iodopyrimidine 
• 478375-42-7 methyl 2-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]acetate 

Downstream Products

• 1201930-30-4 [3-(5-bromopyrimidin-2-yl)phenyl]acetohydrazide 
• 1363569-11-2 3-{3-[5-(2-methoxyethoxy)pyrimidin-2-yl]benzyl}-1,2,4-triazolo[4,3-b]pyridazine-6-carboxylic acid 
• 1231994-88-9 methyl 3-[3-(5-bromopyrimidin-2-yl)benzyl]-1,2,4-triazolo[4,3-b]pyridazine-6-carboxylate 
• 1231994-89-0 butyl 3-[3-(5-bromopyrimidin-2-yl)benzyl]-1,2,4-triazolo[4,3-b]pyridazine-6-carboxylate 
• 1231994-90-3 3-[3-(5-bromopyrimidin-2-yl)benzyl]-1,2,4-triazolo[4,3-b]-pyridazine-6-carboxylic acid 
• 1231994-91-4 N-methyl-3-[3-(5-bromopyrimidin-2-yl)benzyl]-1,2,4-triazolo[4,3-b]pyridazine-6-carboxamide 
• 1363569-04-3 C₂₄H₂₅BN₆O₄ 
• 1363569-09-8 C₁₈H₁₄N₆O₃ 
• 1363569-10-1 C₂₁H₂₀N₆O₄ 
• 1363569-15-6 N-isopropyl-3-{3-[5-(2-methoxyethoxy)pyrimidin-2-yl]benzyl}-1,2,4-triazolo[4,3-b]pyridazine-6-carboxamide 
• 1363568-18-6 C₁₇H₁₃IN₆O 
• 1231995-00-8 6-methoxy-3-{3-[5-(4-methylpiperazin-1-yl)pyrimidin-2-yl]-benzyl}-1,2,4-triazolo[4,3-b]pyridazine 

Relevant articles and documents

3-(3-PYRIMIDIN-2-YLBENZYL)-1,2,4-TRIAZOLO[4,3-B]PYRIDAZINE DERIVATIVES AS MET KINASE INHIBITORS

Compounds of the formula (I), in which R1, R2, R3, R3′, R4 have the meanings indicated in Claim 1, are inhibitors of tyrosine kinases, in particular of Met kinase, and can be employed, inter alia, for the treatment of tumours.

3 (3-Pyrimidin-2-ylbenzyl)-1,2,4-triazolo[4,3-b]pyridazine derivatives

Compounds of the formula (I), in which R1, R2, R3, R3′, R4 have the meanings indicated in claim 1, are inhibitors of tyrosine kinases, in particular Met kinase, and can be employed, inter alia, for th